Smoking cessation treatments: current psychological and pharmacological options
García-Gómez, Leonor; Hernández-Pérez, Andrea; Noé-Díaz, Valeri; Riesco-Miranda, Juan Antonio; Jiménez-Ruiz, Carlos.
Rev. invest. clín
; 71(1): 7-16, Jan.-Feb. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1289665
Documentos relacionados
SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS.
How can hospitals change practice to better implement smoking cessation interventions? A systematic review.
[Clinical Practice Guidelines for Smoking Cessation].
Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy.
Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
Efficacy of Presurgical Interventions to Promote Smoking Cessation: A Systematic Review.
Effects of varenicline and bupropion on laboratory smoking outcomes: Meta-analysis of randomized, placebo-controlled human laboratory studies.
Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
[Smoking cessation and schizophrenia].
Interventions for waterpipe smoking cessation.